ICPT Overview
Upcoming Projects (ICPT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ICPT)
-
2 Week Delay: Survey on Primary Biliary Cholangitis (PBC) and CymaBay Therapeutics’ Seladelpar
Tickers: CBAY, ICPT, GNFT, CVX
Executed On: Jan 10, 2024 at 06:12 PM EST -
Comparing 89bio's ENLIVEN data (pegozafermin) to Akero's efruxifermin in NASH
Tickers: ETNB, AKRO, MDGL, ICPT
Executed On: Mar 23, 2023 at 02:30 PM EDT -
Another view: A look at resmetirom and the upcoming 52 week biopsy results of the phase 3 MAESTRO-NASH trial
Tickers: MDGL, LLY, AKRO, ICPT
Executed On: Nov 23, 2022 at 11:00 AM EST -
A look at resmetirom and the upcoming 52 week biopsy results of the phase 3 MAESTRO-NASH trial
Tickers: MDGL, LLY, AKRO, ICPT
Executed On: Nov 18, 2022 at 03:00 PM EST -
A Second Opinion: Digging into the current and developing treatment landscape for Nonalcoholic steatohepatitis (NASH)
Tickers: ICPT, NVO, MDGL
Executed On: Aug 01, 2022 at 12:00 PM EDT -
Digging into the current and developing treatment landscape for Nonalcoholic steatohepatitis (NASH)
Tickers: ICPT, MDGL, NVO
Executed On: Jul 13, 2022 at 03:00 PM EDT
Upcoming & Overdue Catalysts (ICPT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ICPT)
-
Intercept (ICPT) Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH
Ticker: ICPT
Occurred on: Jun 29, 2020 -
FDA Accepts Intercept’s (ICPT) NDA for Obeticholic Acid in Liver Fibrosis Due to NASH and Grants Priority Review
Ticker: ICPT
Occurred on: Nov 25, 2019 -
Intercept Pharmaceuticals (ICPT) plans to commence Phase 2 INT-767 trial in the second half of 2017
Ticker: ICPT
Occurred on: Apr 17, 2018 -
Intercept Pharmaceuticals (ICPT) plans to commence Phase 3 obeticholic acid (OCA) cirrhosis trial in the second half of 2017
Ticker: ICPT
Occurred on: Feb 12, 2018 -
ICPT's Phase 2 data for Obeticholic acid trials in PSC Expected Mid 2017
Ticker: ICPT
Occurred on: Jul 31, 2017 -
FDA Grants Accelerated Approval to Ocaliva (Obeticholic Acid) for the Treatment of Patients with PBC
Ticker: ICPT
Occurred on: May 27, 2016 -
PDUFA May 29 2016 of Obeticholic acid (OCA) for Primary biliary cirrhosis (PBC)
Ticker: ICPT
Occurred on: May 27, 2016 -
Ocaliva (obeticholic acid) PDUFA Date set for May 29, 2016
Ticker: ICPT
Occurred on: May 27, 2016 -
Intercept Announces New OCA Data in PBC and NASH to be Presented at EASL 2016
Ticker: ICPT
Occurred on: Apr 14, 2016 -
FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva (obeticholic acid) for the Treatment of PBC
Ticker: ICPT
Occurred on: Apr 07, 2016 -
Advisory Committee meeting April 7 2016
Ticker: ICPT
Occurred on: Apr 07, 2016
Strategic Initiatives (ICPT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
